Corticosteroid-induced central serous chorioretinopathy in patients with Ocular Toxoplasmosis Merih Soylu, MD, Prof. Ophthalmology, Füsun Uzunoğlu, MD.

Slides:



Advertisements
Similar presentations
Grand Rounds Peripheral Exudative Hemorrhagic Chorioretinopathy
Advertisements

Macular Invovement in Posterior Uveitis
Diabetic Retinopathy Keri Burton Marissa Ramirez Okono Stacey Garner Stephany Harris.
OCT OF MCULAR DISEASES DEHGHANI.A near infrared light near infrared light cross-sectional images of tissue cross-sectional images of tissue High resolution)
Rites of Sight Your Second 50 years A Presentation of the American Optometric Association.
Central Serous Chorioretinopathy rare but typical changes Dr Edi Ladavac Department of Ophthalmology General Hospital, Pula.
Grand Rounds Niloofar Piri, MD Jan 17th  CC: Blind spots and blurry vision OU for more than 2 years (OS more severely affected)  HPI: A 74-y Caucasian.
CENTRAL SEROUS RETINOPATHY (C.S.R)(C.S.C)
Grand Rounds Best Disease Mark Sherman MD University of Louisville Department of Ophthalmology and Visual Sciences 04/04/2014.
Grand Rounds Scleromalacia Amir R. Hajrasouliha, M.D. University of Louisville Department of Ophthalmology and Visual Sciences Friday, January 17, 2014.
Optical Coherence tomography Imaging of Spontaneous closure of Psuedophakic full thickness macular hole, 8 months post operative Dr. Jenin Patel Lotus.
Optic disk edema and macular serous retinal detachment as an early sign of Bartonella henselae systemic infection Dr. Carlos Alvarez-Guzmán 1 Dr. Alejandro.
FFA Dr Aaron Ng. FFA Principles Fluorescence – Stimulated by light of shorter wavelength – Emission of light of longer wavelength Flurescein – Excitation.
ARAVIND EYE CARE SYSTEM Aravind Eye Hospital & Postgraduate Institute of Ophthalmology ARAVIND EYE CARE SYSTEM Aravind Eye Hospital & Postgraduate Institute.
Sophia M. Chung, M.D. Depts of Ophthalmology &
Basics of outpatient depression management Chris Zamani MD.
Josephine-Liezl Cueto, M.D.* Kendall R. Dobbins, M.D.* Geisinger Medical Center, Department of Ophthalmology Danville, PA *No financial interest.
CASE IV CORNEAL HYDROPS.
A Randomized Trial of Peribulbar Triamcinolone Acetonide with and without Focal Photocoagulation for Mild Diabetic Macular Edema: A Pilot Study.
Quize of the week Hajer AlZuhair Medical resident.
Phototoxic Maculopathy After Scleral Sutured IOL Implantation NC CHO, DW LEE, EY KWEON, MJ KIM Department of Ophthalmology, Chonbuk National University.
Update on Prevention, Diagnosis & Treatment of Diabetic Macular Edema (DME) Part 2 A. Paul Chous, MA, OD, FAAO Specializing in Diabetes Eye Care & Education.
Paulo Silva Guerra, Margarida Miranda, Joana Couceiro, Walter Rodrigues, M. Monteiro Grillo Ophthalmology Department - Hospital de Santa Maria. Director:
Uveitic Macular Edema Nihal Elshakankiry, MD, PhD Professor of Ophthalmology Rowayda M. Amin, MSc Assistant Lecturer of Ophthalmology Alexandria University.
Eales' disease Dr Chinmayi Vyas M.S. Dr Jyotirmay Biswas
Aravind Eye Hospital, Madurai
Acute Retinal Pigment Epithelitis
Advanced Eye Centre and Department of Neurology*
Behcet's Disease in an Indian Patient
Vogt Koyanagi-Harada Luca Cimino Luca Cappuccini
Surgical Therapy of CME Non-responsive to Medical Therapy Henry J Kaplan, MD Evans Professor of Ophthalmology Chair, Ophthalmology & Visual Sciences Director,
Assist. Lecturer of Ophthalmology
Chikungunya Retinitis
Cat Scratch Disease Rupesh Agrawal, Carlos Pavesio
Bartonella Neuroretinitis
Ahmed Y. Hatata, MSc Rowayda M. Amin, MSc Assistant Lecturer Ophthalmology Alexandria University, Egypt Toxocariasis.
Neuroretinitis Anna-Maria Gerlach, Werner Inhoffen Deshka Doycheva, Manfred Zierhut Centre of Ophthalmology University of Tuebigen Germany.
MULTI-NODULAR POSTERIOR SCLERITIS Dr Nilutpal Borah, M.S. Guwahati Eye Institute and Research Center Assam, India.
ACUTE RETINAL NECROSIS
Persistent placoid Maculopathy TB related Rupesh Agrawal, Carlos Pavesio Moorfields Eye Hospital, NHS Foundation Trust, London, United Kingdom.
OPHTHALMOLOGY MACULA DEGENERATION MBChB 4 Prof P Roux 2012.
Central serous chorioretinopathy and uveitis Central serous chorioretinopathy and uveitis Rim Kahloun, MD Sonia Zaouali, MD Moncef Khairallah, MD Moncef.
Behçet´s Disease Christoph Deuter Centre for Ophthalmology, University Hospital, Tuebingen, Germany.
Centre of Ophthalmology University of Tuebingen, Germany
Posterior Scleritis associated with Orbital Pseudotumor Nikolas London, MD Retina Consultants San Diego.
Cryptococcus choroiditis
Choroidal Tuberculoma Rupesh Agrawal, Carlos Pavesio Moorfields Eye Hospital, NHS Foundation Trust, London, United Kingdom.
Acute choroidal ischemia and Toxoplasmic Retinochoroiditis Acute choroidal ischemia and Toxoplasmic Retinochoroiditis Sonia Attia, MD Imen Ksiaa, MD Moncef.
Vitrase (Hyaluronidase for Injection) Advisory Committee Meeting March 17, 2003 Jennifer D. Harris, MD Medical Officer Division of Anti-inflammatory, Analgesic,
Sympathetic Ophthalmitis Annie Mathai, Rajeev K Reddy, Hemant S Trehan, Ritesh Narula Smt.Kanuri Santhamma Retina Vitreous Centre, Kallam Anji Reddy Campus,
COMPARATIVE EFFICACY OF INTRAVITREAL BEVACIZUMAB AND RANIBIZUMAB IN THE TREATMENT OF DIABETIC MACULAR OEDEMA J.A. Montero, J.M. Ruiz-Moreno VISSUM, Alicante.
Punctate Inner Choroidopathy Ahmed Magdy Bedda, MD, PhD Professor of Ophthalmology Rowayda M. Amin, MSc Assistant lecturer of Ophthalmology Alexandria.
Toxoplasmic Retinochoroiditis Rupesh Agrawal, Carlos Pavesio Moorfields Eye Hospital, NHS Foundation Trust, London, United Kingdom.
Date of download: 6/1/2016 The Association for Research in Vision and Ophthalmology Copyright © All rights reserved. From: Optical Coherence Tomography.
Primary Inflammatory Choriocapillaropathy Rupesh Agrawal, Carlos Pavesio Moorfields Eye Hospital, NHS Foundation Trust, London, United Kingdom.
CATT objectives To determine whether off-lable “Avastin” works as well as approved medication for neovascular AMD- “Lucentis” To evaluate how often treatment.
Sympathetic Ophthalmitis
Ocular injuries secondary to alexandrite laser-assisted hair removal
AGE-RELATED MACULAR DEGENERATION (AMD)
Ophthalmic Res 2017;57: DOI: /
Consultant, Uveitis Service
Inflammatory Chorioretinopathies of Unknown Etiology
Vogt-Koyanagi Harada Disease
Inflammatory choroidal neovascularization
Multiple evanescent white dot syndrome
The Role of Lucentis in the treatment of Visual impairment due to Diabetic Macula Oedema Dr Dan Bwonya Mengo Hospital,
Acute Placoid Multifocal Posterior Pigment Epitheliopathy
Multiple Evanescent White Dot Syndrome (MEWDS)
Presentation transcript:

Corticosteroid-induced central serous chorioretinopathy in patients with Ocular Toxoplasmosis Merih Soylu, MD, Prof. Ophthalmology, Füsun Uzunoğlu, MD World Eye Hospital, TURKEY Development of central serous chorioretinopathy (CSC) following the administration of corticosteroids is a well-known fact. Especially in patients with uveitis in whom corticocosteroids are widely used, it is very important to make the differential diagnosis between a new inflammatory episode or another pathology like CSCR. In these patients discontinuation of steroids is mandatory, and it should be done with careful monitorisation of the disease activity. In the present study, two cases with ocular toxoplasmosis who developed CSCR during treatment is presented. The symptoms appeared concurrently during treatment with antibiotic/steroid treatment of the underlying disease, and resolved after cessation of steroids. This study is undertaken in order to emphasize the importance of monitoring patients under treatment with steroids.

CASE 1 Fig 1 –RE a. Healing chorioretinal scar and old scars. b. Early phase FFA with hypofluorescent foci c. Late phase FFA with hyperfluorescent borders of the lesion and window defects on the posterior pole Fig 2-LE a, b. Serous detachment of the macula. Fundus photo and OCT c. FFA, showing pinpoint hyperfluorescence and minimal leakage c 27 y/old F Decrease of vision in the left eye while receiving therapy for toxoplasmic chorioretinitis in her RE. She has been under Clindamycine and prednisolone treatment for the last two months, and having gastrointestinal problems. Upon admission, she was diagnosed as CSCR in the LE. The therapy was stopped, a single dose of peribulbar depot betamethasone was injected to the RE, and sulfadiazine- trimethoprim combination was started. After 3 months, vision was improved, and CSCR resolved. No recurrences were detected during 18 months of follow-up.

CASE 2 37 y/o M Visual detoriation in the normal eye, started during antitoxoplasmosis treatment for the activation in the fellow eye. Before admission, he stopped taking daraprim by himself because of side effects, and continued treatment only with steroids. On admission, he had CSCR in his RE and focal chorioretinal scar in the LE. VA was 0.16 OU. Acetozolamide with topical and systemic NSAID was started, systemic steroids were tapered and discontinued. His VA returned to 1.0 in his RE, after cessation of steroids. He has been followed for a year and no recurrences were detected during this period.

Fig. 3- FAF and FFA at presentation. Note the hypoautofluororescence in the LE in the areas of chorioretinal scarring, and hyperautofluororescen spots in both eyes. In FFA, there is a 2 spots of pinpoint leakage on the upper side of the fovea in RE, whereas hyperfluorescence in the borders of the scar in the LE. Fig. 4-There is a serous elevation in the macula in RE and multipl reverbaration echoing in the LE due to scarring at presentation. Central macular thickness was 640 mμ in the RE. CASE 2

Fig days after tapering off steroids and starting acetozolamide and non-steroid antiinflammory treatment. CMT was 411 mμ. Note the hyperreflective spots in the retina. Fig days after presentation, there is still some serous fluid in the macula (CMT 278 mμ). BCVA was 1.0. Fig. 7- Two months after presentation, macula is on without any residual fluid, and anatomical recovery is good, without any change in outer retinal layers.

DISCUSSION In clinical practice, corticosteroids are usually given in combination with antiparasitic drugs to reduce the inflammatory reaction during active chorioretinitis and to minimize tissue damage in ocular toxoplasmosis. Besides causing ocular side effects, corticosteroids increases fragility and hyperpermeability of capillaries, increases free radicals, inhibit collagen production, changes ion and water transportation. Clearly the chance of significant side effects increases with dose and duration of treatment, therefore minimum dose necessary to control the disease should be given and tapered slowly in order to prevent rebound effect. In our first visit with the patient, besides her declining vision, complained about irritability, gastrointestinal symptoms, weight gain and fatigue. After stopping the medications and switching to a single dose depot steroid, the steroid side effects resolved. We added sulfadiazine- trimetoprim to the regimen, thus providing a cover for the continuing slow release of steroids, with fewer side effects and well tolerated by the patient. CSCR is a relatively common chorio-retinal disease characterized by the accumulation of subretinal fluid at the posterior pole, creating a circumscribed area of serous retinal detachment. CSCR has been described in patients with endogenous hypercorticolism. Toxoplasmic chorioretinitis treatment or any treatment protocol with corticosteroids can cause CSCR, not related to dosage and duration of therapy. Presentation of CSCR due to toxoplasmic chorioretinitis therapy is very rare. However, the potential side effects of corticosteroids, favoring CSC, are well-known. When an unexpected clinical and angiographic change compatible with CSC develops in a patient under antitoxoplasmic therapy, overuse or improper use of steroids should be kept in mind as a causative agent. This report emphasizes the necessity of thorough evaluation and close follow-up, and monitoring treatment agents in patients under toxoplasma treatment.